People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amytrx Therapeutics, Inc. | — | Pharmaceuticals | Seed | $7.0M | $4.6M | 2020 |
Thomas Andrews at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Andrews on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lawrence W> Greer | 1 | 4 |
| Michael Howell | 1 | 3 |
| Thomas G. Andrews | 1 | 2 |
| Matthew A Gonda | 1 | 2 |
| Dennis J. Carlo | 1 | 2 |
| Dennis Carlo | 1 | 2 |
| Robert E McNeilly | 1 | 1 |
| Raymond M Pirtle | 1 | 1 |
| Larry Greer | 1 | 1 |
| Raymond J Pirtle | 1 | 1 |
| Matthew Gonda | 1 | 1 |
| Lawrence Greer | 1 | 1 |
| Satish Joshi | 1 | 1 |
| Raymond Pirtle | 1 | 1 |
| Daniel Pirtle | 1 | 1 |
| Daniel Canale | 1 | 1 |
| Jerry M Kluft | 1 | 1 |
| Lawrence G Greer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.